Acadia Healthcare lowers 2025 guidance after actuarial review shows $49M PLGL expense increase

Acadia Healthcare Company, Inc.

Adjusted EBITDA guidance reduced to $601-611M from $650-660M; adjusted EPS to $1.94-2.04 from $2.35-2.45.
2025 PLGL expense projected ~$116M, up from $54M in 2024, driven by 168% increase in claim frequency for 2025 policy year.
Net PLGL liability expected to rise to $145-165M at year-end 2025 from $78M at end of 2024.
For 2026, PLGL expense expected between $100M and $110M, reflecting assumption of sustained claim frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.